skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

New regulatory and drug pricing policies are negatively impacting growth in the Indian pharmaceutical sector, but opportunities remain.


Highlights in this whitepaper include:

  • The effect of tighter regulations on the number of clinical trials conducted in India
  • The impact of inadequate patent protection for branded players and domestic generic manufacturers
  • The challenges faced with compulsory licensing of patented drugs
  • The result the expanding pricing controls will have on the multinational companies
  • Cheap generic medicines vs. branded manufacturers
  • Opportunities and challenges for multinational companies
Indian Pharmaceutical Market

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: